NASDAQ:PRPO - Precipio Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.1704 -0.01 (-5.54 %)
(As of 02/21/2019 06:00 AM ET)
Previous Close$0.1780
Today's Range$0.17 - $0.18
52-Week Range$0.15 - $1.75
Volume2.17 million shs
Average Volume3.21 million shs
Market Capitalization$5.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.11
Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. The company is based in New Haven, Connecticut.

Receive PRPO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPO
CUSIPN/A
Phone203-787-7888

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.72 million
Book Value$1.28 per share

Profitability

Net Income$-20,690,000.00
Net Margins-610.39%

Miscellaneous

Employees33
Market Cap$5.18 million
OptionableNot Optionable

Precipio (NASDAQ:PRPO) Frequently Asked Questions

What is Precipio's stock symbol?

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

When did Precipio's stock split? How did Precipio's stock split work?

Precipio shares reverse split on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.

How were Precipio's earnings last quarter?

Precipio Inc (NASDAQ:PRPO) released its earnings results on Thursday, August, 23rd. The biotechnology company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of $1.93 by $2.08. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative net margin of 610.39% and a negative return on equity of 149.24%. View Precipio's Earnings History.

Has Precipio been receiving favorable news coverage?

Press coverage about PRPO stock has been trending somewhat positive on Thursday, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Precipio earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the near term.

Are investors shorting Precipio?

Precipio saw a decline in short interest in January. As of January 31st, there was short interest totalling 670,802 shares, a decline of 55.1% from the January 15th total of 1,494,113 shares. Based on an average daily volume of 1,502,323 shares, the days-to-cover ratio is presently 0.4 days. Approximately 2.5% of the shares of the company are short sold. View Precipio's Current Options Chain.

Who are some of Precipio's key competitors?

Who are Precipio's key executives?

Precipio's management team includes the folowing people:
  • Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 47)
  • Mr. Carl R. Iberger, CFO & Sec. (Age 66)
  • Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 33)
  • Mr. Douglas Sites, VP of Sales
  • Mr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 34)

How do I buy shares of Precipio?

Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Precipio's stock price today?

One share of PRPO stock can currently be purchased for approximately $0.1704.

How big of a company is Precipio?

Precipio has a market capitalization of $5.18 million and generates $1.72 million in revenue each year. Precipio employs 33 workers across the globe.

What is Precipio's official website?

The official website for Precipio is http://www.precipiodx.com.

How can I contact Precipio?

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected]


MarketBeat Community Rating for Precipio (NASDAQ PRPO)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  176 (Vote Outperform)
Underperform Votes:  122 (Vote Underperform)
Total Votes:  298
MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel